RAPP · Company research
Rapport Therapeutics, Inc. (RAPP): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 31.15 | $1,587,502,938.56 | 1523890938.56 | — | — | — | 79.3751469280000000 | 3.7536186911185408 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.